BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 7545891)

  • 21. Endothelial dysfunction and neutrophil adherence as critical events in the development of reperfusion injury.
    Lefer AM; Ma XL; Weyrich A; Lefer DJ
    Agents Actions Suppl; 1993; 41():127-35. PubMed ID: 8317336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutrophil-endothelial cell interactions in vivo: a chain of events characterized by distinct molecular mechanisms.
    von Andrian UH; Arfors KE
    Agents Actions Suppl; 1993; 41():153-64. PubMed ID: 8317339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of neutrophils in myocardial ischemia-reperfusion injury.
    Jordan JE; Zhao ZQ; Vinten-Johansen J
    Cardiovasc Res; 1999 Sep; 43(4):860-78. PubMed ID: 10615413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute lung injury: the role of cytokines in the elicitation of neutrophils.
    Strieter RM; Kunkel SL
    J Investig Med; 1994 Dec; 42(4):640-51. PubMed ID: 8521027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blockade of selectin-mediated leukocyte adhesion improves postischemic function in lamb hearts.
    Miura T; Nelson DP; Schermerhorn ML; Shin'oka T; Zund G; Hickey PR; Neufeld EJ; Mayer JE
    Ann Thorac Surg; 1996 Nov; 62(5):1295-300. PubMed ID: 8893560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacology of selectin inhibitors in ischemia/reperfusion states.
    Lefer DJ
    Annu Rev Pharmacol Toxicol; 2000; 40():283-94. PubMed ID: 10836137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complement, neutrophils and free radicals: mediators of reperfusion injury.
    Lucchesi BR
    Arzneimittelforschung; 1994 Mar; 44(3A):420-32. PubMed ID: 8185717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms and therapy of myocardial reperfusion injury.
    Forman MB; Virmani R; Puett DW
    Circulation; 1990 Mar; 81(3 Suppl):IV69-78. PubMed ID: 2407376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbohydrate selectin inhibitor CY-1503 reduces neutrophil migration and reperfusion injury in canine pulmonary allografts.
    Schmid RA; Yamashita M; Boasquevisque CH; Ando K; Fujino S; Phillips L; Cooper JD; Patterson GA
    J Heart Lung Transplant; 1997 Oct; 16(10):1054-61. PubMed ID: 9361248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cardiac dysfunction and endogenous cytokines in global ischemia and reperfusion injury].
    Kamikubo Y
    Hokkaido Igaku Zasshi; 1993 Nov; 68(6):813-26. PubMed ID: 8112707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adhesion molecules and inflammatory injury.
    Albelda SM; Smith CW; Ward PA
    FASEB J; 1994 May; 8(8):504-12. PubMed ID: 8181668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selectin on activated platelets enhances neutrophil endothelial adherence in myocardial reperfusion injury.
    Kogaki S; Sawa Y; Sano T; Matsushita T; Ohata T; Kurotobi S; Tojo SJ; Matsuda H; Okada S
    Cardiovasc Res; 1999 Sep; 43(4):968-73. PubMed ID: 10615424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blockade of platelet endothelial cell adhesion molecule-1 protects against myocardial ischemia and reperfusion injury in cats.
    Murohara T; Delyani JA; Albelda SM; Lefer AM
    J Immunol; 1996 May; 156(9):3550-7. PubMed ID: 8617985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion.
    Lefer AM; Lefer DJ
    Cardiovasc Res; 1996 Oct; 32(4):743-51. PubMed ID: 8915192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coronary endothelial dysfunction after ischemia and reperfusion and its prevention by ischemic preconditioning.
    Pagliaro P; Chiribiri A; Mancardi D; Rastaldo R; Gattullo D; Losano G
    Ital Heart J; 2003 Jun; 4(6):383-94. PubMed ID: 12898803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rolling dynamics of a neutrophil with redistributed L-selectin.
    King MR; Sumagin R; Green CE; Simon SI
    Math Biosci; 2005 Mar; 194(1):71-9. PubMed ID: 15836865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphonuclear leukocyte-induced vasocontraction and endothelial dysfunction. Role of selectins.
    Murohara T; Buerke M; Lefer AM
    Arterioscler Thromb; 1994 Sep; 14(9):1509-19. PubMed ID: 7520747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Damage from reperfusion: no-reflow phenomenon].
    Lamaida N; Capuano V; Bifulco M; Palma M; De Martino M
    Minerva Cardioangiol; 1993 Oct; 41(10):469-74. PubMed ID: 7508096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival in lung reperfusion injury is improved by an antibody that binds and inhibits L- and E-selectin.
    Steinberg JB; Mao HZ; Niles SD; Jutila MA; Kapelanski DP
    J Heart Lung Transplant; 1994; 13(2):306-18. PubMed ID: 7518251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time course of coronary vascular endothelial adhesion molecule expression during reperfusion of the ischemic feline myocardium.
    Weyrich AS; Buerke M; Albertine KH; Lefer AM
    J Leukoc Biol; 1995 Jan; 57(1):45-55. PubMed ID: 7530283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.